Granules India shares gain on US FDA approval for generic of Cuprimine, Penicillamine capsules
Granules India announced that the US FDA has approved the ANDA filed by Granules Pharmaceuticals, Inc (GPI)., for Penicillamine Capsules USP, 250 mg, the company said in an exchange filing.